BackChugai Pharmaceutical , Ltd. Overview

Chugai Pharmaceutical , Ltd. Long Term Debt

Latest long-term debt for CHGCF: $16B.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$16.14B
↑ 31.52% YoYΔ $3.87B vs prior year quarter

Peer trimmed avg / median

Loading

Chugai Pharmaceutical , Ltd. Long Term Debt History

Loading

Chugai Pharmaceutical , Ltd. vs. peers: Long Term Debt Comparison

Loading

Chugai Pharmaceutical , Ltd. Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Chugai Pharmaceutical , Ltd. (CHGCF) FAQ

The latest long-term debt for CHGCF is $16B as of September 2026. That compares with $12B in the prior-year period — up 31.5% year over year. Investors often review this figure alongside Chugai Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CHGCF's long-term debt moved from $12B to $16B — a 31.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chugai Pharmaceutical , Ltd.'s operating scale or balance-sheet position.

A long-term debt figure of $16B for CHGCF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CHGCF's long-term debt ($16B), review year-over-year change from $12B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.